About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Experian: Become the first personal finance app to integrate with Google's (GOOG.O) Gemini.

2026-09-24

Experian: Become the first personal finance app to integrate with Google's (GOOG.O) Gemini.

Other News
2026-09-23

The OECD said on Wednesday that AI-driven investment has modestly boosted global growth this year but a Middle East commodity-price shock is weighing on the 2027 outlook. After 3.4% growth last year, the OECD’s mid-term outlook projects global growth

The OECD said on Wednesday that AI-driven investment has modestly boosted global growth this year but a Middle East commodity-price shock is weighing on the 2027 outlook. After 3.4% growth last year, the OECD’s mid-term outlook projects global growth of 2.9% in 2026, slightly above its June forecast of 2.8%, and only 3.0% in 2027, below June’s 3.1% projection. Strong AI infrastructure spending — from data centers to semiconductors — has supported US growth and lifted tech exports from Japan and South Korea. The OECD flagged downside risks from energy-market volatility, a strong El Nifio, rising government bond yields and disappointing returns on AI investment; if realized, these could shave 0.7 percentage point off global growth and push global inflation up by 1.1 percentage point next year.
2026-09-23

Novo Nordisk said it is open to upgrading its U.S. listing — potentially replacing its American depositary receipts with a direct New York listing — as the Danish maker of weight‑loss drugs seeks greater U.S. visibility. Asked whether the company wou

Novo Nordisk said it is open to upgrading its U.S. listing — potentially replacing its American depositary receipts with a direct New York listing — as the Danish maker of weight‑loss drugs seeks greater U.S. visibility. Asked whether the company would consider listing shares directly on the NYSE instead of ADRs, the CEO said he saw advantages and would not rule it out but added the company is not currently studying the option. He noted rival AstraZeneca made a similar move earlier this year.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.